[{"indications": "Indications\u00a0see under Dose", "name": "RISEDRONATE SODIUM With calcium carbonate and colecalciferol", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.6 Drugs affecting bone metabolism", "6.6.2 Bisphosphonates and other drugs affecting bone metabolism", "Bisphosphonates", "RISEDRONATE SODIUM", "With calcium carbonate and colecalciferol"], "cautions": "Cautions\u00a0oesophageal abnormalities and other factors\r\nwhich delay transit or emptying (e.g. stricture or achalasia\u2014see also under Side-effects); correct hypocalcaemia before starting, correct other disturbances of bone and mineral metabolism (e.g.\r\nvitamin-D deficiency) at onset of treatment; consider dental check-up before initiating bisphosphonate (risk of osteonecrosis of the jaw, see Bisphosphonates: Osteonecrosis\r\nof the Jaw); atypical femoral fractures, see MHRA/CHM advice; interactions: Appendix 1 (bisphosphonates)", "side-effects": "Side-effects\u00a0abdominal pain, dyspepsia, nausea, diarrhoea,\r\nconstipation, headache, musculoskeletal pain; less commonly oesophagitis, oesophageal ulcer, dysphagia, gastritis, duodenitis,\r\nuveitis; rarely glossitis, oesophageal stricture,\r\natypical femoral fractures (see MHRA/CHM advice); also reported gastroduodenal ulceration, hepatic disorders,\r\nStevens-Johnson syndrome, toxic epidermal necrolysis, hair loss, cutaneous\r\nvasculitis, osteonecrosis of the jaw (see Bisphosphonates: Osteonecrosis\r\nof the Jaw)Oesophageal reactions\u00a0Patients should\r\nbe advised to stop taking the tablets and seek medical attention if\r\nthey develop symptoms of oesophageal irritation such as dysphagia,\r\npain on swallowing, retrosternal pain, or heartburn", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/200960.htm", "doses": ["Paget\u2019s disease of bone, 30\u00a0mg daily for 2 months; may\r\nbe repeated if necessary after at least 2 months", "Treatment of postmenopausal osteoporosis to reduce risk of vertebral\r\nor hip fractures, 5\u00a0mg daily or  35\u00a0mg once weekly", "Prevention of osteoporosis (including corticosteroid-induced\r\nosteoporosis) in postmenopausal women, 5\u00a0mg daily", "Treatment of osteoporosis in men at high risk of fractures,\r\n35\u00a0mg once weekly", "child see BNF for Children", "Swallow tablets whole with full glass\r\nof water; on rising, take on an empty stomach at least 30 minutes\r\nbefore first food or drink of the day or, if taking\r\nat any other time of the day, avoid food and drink for at least 2\r\nhours before or after risedronate (particularly avoid calcium-containing\r\nproducts e.g. milk; also avoid iron and mineral supplements and antacids);\r\nstand or sit upright for at least 30 minutes; do not take tablets\r\nat bedtime or before rising", "Name[Actonel\u00ae Combi (Warner Chilcott) ] Tablets, f/c, orange, risedronate\r\nsodium 35\u00a0mg (Actonel Once a Week\u00ae);\nGranules, effervescent, lemon flavour,\r\ncalcium carbonate 2.5\u00a0g (calcium 1\u00a0g or Ca2+ 25\u00a0mmol) and\r\ncolecalciferol 22\u00a0micrograms (880\u00a0units)/sachet, net price 24-sachet\r\nplus 4-tab pack = \u00a319.12. Counselling, administration, food and calcium\r\n(see above)Dose\u00a0treatment of postmenopausal osteoporosis to reduce risk\r\nof vertebral or hip fractures, given in weekly cycles, 1 Actonel Once a Week\u00ae tablet on the first day followed by\r\n1 calcium and colecalciferol sachet daily for 6 daysCounselling\u00a0 Tablets should be swallowed whole\r\nwith plenty of water while sitting or standing; to be taken on an\r\nempty stomach at least 30 minutes before breakfast (or another oral\r\nmedicine); patient should stand or sit upright for at least 30 minutes\r\nafter taking tablet. Granules should be stirred into a glass of water\r\nand after dissolution complete taken immediately"], "pregnancy": "Pregnancy\u00a0avoid"}, {"indications": "Indications\u00a0see under Dose", "name": "RISEDRONATE SODIUM", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.6 Drugs affecting bone metabolism", "6.6.2 Bisphosphonates and other drugs affecting bone metabolism", "Bisphosphonates", "RISEDRONATE SODIUM"], "cautions": "Cautions\u00a0oesophageal abnormalities and other factors\r\nwhich delay transit or emptying (e.g. stricture or achalasia\u2014see also under Side-effects); correct hypocalcaemia before starting, correct other disturbances of bone and mineral metabolism (e.g.\r\nvitamin-D deficiency) at onset of treatment; consider dental check-up before initiating bisphosphonate (risk of osteonecrosis of the jaw, see Bisphosphonates: Osteonecrosis\r\nof the Jaw); atypical femoral fractures, see MHRA/CHM advice; interactions: Appendix 1 (bisphosphonates)", "side-effects": "Side-effects\u00a0abdominal pain, dyspepsia, nausea, diarrhoea,\r\nconstipation, headache, musculoskeletal pain; less commonly oesophagitis, oesophageal ulcer, dysphagia, gastritis, duodenitis,\r\nuveitis; rarely glossitis, oesophageal stricture,\r\natypical femoral fractures (see MHRA/CHM advice); also reported gastroduodenal ulceration, hepatic disorders,\r\nStevens-Johnson syndrome, toxic epidermal necrolysis, hair loss, cutaneous\r\nvasculitis, osteonecrosis of the jaw (see Bisphosphonates: Osteonecrosis\r\nof the Jaw)Oesophageal reactions\u00a0Patients should\r\nbe advised to stop taking the tablets and seek medical attention if\r\nthey develop symptoms of oesophageal irritation such as dysphagia,\r\npain on swallowing, retrosternal pain, or heartburn", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/119694.htm", "doses": ["Paget\u2019s disease of bone, 30\u00a0mg daily for 2 months; may\r\nbe repeated if necessary after at least 2 months", "Treatment of postmenopausal osteoporosis to reduce risk of vertebral\r\nor hip fractures, 5\u00a0mg daily or  35\u00a0mg once weekly", "Prevention of osteoporosis (including corticosteroid-induced\r\nosteoporosis) in postmenopausal women, 5\u00a0mg daily", "Treatment of osteoporosis in men at high risk of fractures,\r\n35\u00a0mg once weekly", "child see BNF for Children", "Swallow tablets whole with full glass\r\nof water; on rising, take on an empty stomach at least 30 minutes\r\nbefore first food or drink of the day or, if taking\r\nat any other time of the day, avoid food and drink for at least 2\r\nhours before or after risedronate (particularly avoid calcium-containing\r\nproducts e.g. milk; also avoid iron and mineral supplements and antacids);\r\nstand or sit upright for at least 30 minutes; do not take tablets\r\nat bedtime or before rising"], "pregnancy": "Pregnancy\u00a0avoid"}]